November 19, 2015 / 12:46 AM / 2 years ago

Pfizer discussing Allergan offer at $370-$380 per share: source

(Reuters) - Pfizer Inc (PFE.N) is in talks to acquire Allergan Plc (AGN.N) for $370-$380 per share, according to a person familiar with the matter, valuing the potential deal at around $150 billion, the healthcare sector’s biggest.

The Pfizer logo is pictured at their building in the Manhattan borough of New York October 29, 2015. REUTERS/Carlo Allegri

    Talks between the sides have accelerated, though the U.S. Treasury’s announcement on the tightening of the rules for tax inversions has made timing more uncertain and a deal is not imminent, the source said, asking not to be identified because the matter is confidential.

    Pfizer declined to comment, while Allergan did not respond to a request for comment.

    Reporting by Greg Roumeliotis in New York; Editing by Sandra Maler

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below